Inventor
SHIHABUDDIN LAMYA
US24 patents
⚠️ This page may combine multiple inventors who share the name “SHIHABUDDIN LAMYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENZYME CORP
7 patentsUS10369193B2Aug 6, 2019
Gene therapy for neurodegenerative disorders
GENZYME CORP17 citations94
US9415119B2Aug 16, 2016
Gene therapy for neurodegenerative disorders
GENZYME CORP13 citations92
US11911440B2Feb 27, 2024
Gene therapy for neurodegenerative disorders
GENZYME CORP5 citations86
US10080783B2Sep 25, 2018
Intraventricular enzyme delivery for lysosomal storage diseases
GENZYME CORP6 citations84
US11975043B2May 7, 2024
Gene therapy for neurodegenerative disorders
GENZYME CORP3 citations75
US12350311B2Jul 8, 2025
Gene therapy for neurodegenerative disorders
GENZYME CORP0 citations62
US11554161B2Jan 17, 2023
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
GENZYME CORP0 citations61
IONIS PHARMACEUTICALS INC
6 patentsUS9683236B2Jun 20, 2017
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC5 citations84
US11421231B2Aug 23, 2022
Modulation of Huntington expression
IONIS PHARMACEUTICALS INC1 citations73
US10837016B2Nov 17, 2020
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC2 citations73
US10619158B2Apr 14, 2020
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC2 citations73
US10202603B2Feb 12, 2019
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC2 citations73
US12297431B2May 13, 2025
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC0 citations60
DODGE JAMES
3 patentsUS9034836B2May 19, 2015
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
DODGE JAMES27 citations91
US8926967B2Jan 6, 2015
Intraventricular enzyme delivery for lysosomal storage diseases
DODGE JAMES13 citations83
US10744210B2Aug 18, 2020
Gene therapy for spinal cord disorders
DODGE JAMES8 citations80